MedTrace Logo

Are Serial Electrocardiograms Additive to SeriAl Second-generations Troponins in Predicting Acute CoronAry Syndromes in PatienTs With Undifferentiated cHest Pain

NCT01953276 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 382

Last updated 2022-02-17

No results posted yet for this study

Summary

Our research will examine whether the presence or absence of serial electrocardiogram (ECG) changes aids in reclassifying participants' risk for major adverse cardiac events (MACE) over and above serial blood testing.

Conditions

Interventions

DEVICE

Serial Electrocardiograms

All participants will have serial electrocardiograms performed.

Sponsors & Collaborators

Principal Investigators

  • Simon Mahler, MD · Wake Forest University Health Sciences

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-05-31
Completion
2018-01-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01953276 on ClinicalTrials.gov